In this blog, we take a look at ClaretBio’s app note on using Horizon’s cfDNA reference standards in the development of their novel sample prep kit.
6 result(s)
Learn how to examine your NGS data to investigate false positives and negatives, and potential downstream applications
Now Horizon's popular reference standards have been exome sequenced for higher confidence and expanded applications. Read on to find out how this new level of product information will support your diagnostics pipeline.
Acute Myeloid Leukaemia (AML) is a group of blood cancer malignancies that originate from the uncontrolled proliferation of blast cells in the bone marrow and circulating blood1. AML is a relatively rare disorder - representing less than 1% of total cancer cases.
See from a real example how Horizon's reference standards can be used to validate a new NGS assay technology.
Top ten recommendations to validate your NGS assay.